Literature DB >> 27163641

Acute rosmarinic acid treatment enhances long-term potentiation, BDNF and GluR-2 protein expression, and cell survival rate against scopolamine challenge in rat organotypic hippocampal slice cultures.

Eun-Sang Hwang1, Hyun-Bum Kim1, Ga-Young Choi2, Seok Lee1, Sung-Ok Lee3, SangSeong Kim4, Ji-Ho Park5.   

Abstract

BACKGROUND: Rosmarinic acid (RA) is a polyphenolic ester of caffeic acid and is commonly found in the Nepetoideae subfamily of flowering mint plants. Because RA has previously exhibited antioxidant, neuroprotective, and antidepressant-like effects, we evaluated its influences on cellular functions in neuronal cultures.
OBJECTIVE: To elucidate possible mechanisms of RA, we investigated the influences of acute RA administration on long-term potentiation (LTP), plasticity-related protein expression, and scopolamine-induced cell death in organotypic hippocampal slice cultures.
METHODS: LTP analysis in organotypic hippocampal slice cultures (OHSCs) was carried out with various ion channel blockers, such as AP5 (10 μM), CNQX (10 μM), niflumic acid (100 μM), and scopolamine (300 μM) in response to RA (1, 10 or 100 μg/mL) treatment. Protein expression and cell death assays in the presence of scopolamine were examined to observe the effects of RA. For LTP analysis, baseline field excitatory postsynaptic potentials (fEPSPs) were recorded in CA1 by a 60-channel multielectrode array (MEA) every min for 40 min before 15 min of high-frequency stimulation (HFS) to the Schaffer collaterals and commissural pathways, followed by a successive 50 min of recording. For protein expression measurements, anti-BDNF and anti-GluR2 antibodies were used for Western blotting assays in whole-hippocampal tissue homogenate. Finally, for cell death assays, OHSCs were exposed to a culture medium containing propidium iodide (PI) for 24 or 48 h, followed by the assessment of cell death by fluorescent image analysis of PI uptake.
RESULTS: and discussion: Our results indicate that RA treatment enhances fEPSPs following HFS in CA1 synapses at 1 and 10 μg/ml RA, an effect that was inhibited by CNQX and NFA but not by AP5. RA treatment also increases the expression of BDNF and GluR-2 proteins and prevents cell death of scopolamine-exposed OHSCs. Our results suggest the possibility that rosmarinic acid can enhance neural plasticity by modulating glutamatergic signaling pathways, as well as providing neuroprotection with reduced cholinergic activity.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Hippocampus; Long-term potentiation (LTP); Multielectrode array (MEA); Neuronal plasticity; Neuroprotection; Rosmarinic acid (RA)

Mesh:

Substances:

Year:  2016        PMID: 27163641     DOI: 10.1016/j.bbrc.2016.04.153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action.

Authors:  Dominik Szwajgier; Kamila Borowiec; Katarzyna Pustelniak
Journal:  Nutrients       Date:  2017-05-10       Impact factor: 5.717

Review 2.  Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease.

Authors:  Giuseppe Caruso; Justyna Godos; Anna Privitera; Giuseppe Lanza; Sabrina Castellano; Alessio Chillemi; Oliviero Bruni; Raffaele Ferri; Filippo Caraci; Giuseppe Grosso
Journal:  Nutrients       Date:  2022-02-15       Impact factor: 5.717

3.  Ethyl Acetate Extract Components of Bushen-Yizhi Formula Provides Neuroprotection against Scopolamine-induced Cognitive Impairment.

Authors:  Shi-Jie Zhang; Dan Luo; Lin Li; Rui-Rong Tan; Qing-Qing Xu; Jie Qin; Lei Zhu; Na-Chuan Luo; Ting-Ting Xu; Rong Zhang; Lei Yang; Qi Wang
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

4.  Rosmarinic acid ameliorates hypoxia/ischemia induced cognitive deficits and promotes remyelination.

Authors:  Man Li; Miao-Miao Cui; Nwobodo Alexander Kenechukwu; Yi-Wei Gu; Yu-Lin Chen; Si-Jing Zhong; Yu-Ting Gao; Xue-Yan Cao; Li Wang; Fu-Min Liu; Xiang-Ru Wen
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.